Roche Holding AG - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
RHHBY Over the counter 2830 www.roche.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Roche Holding AG

Dear Eli Lilly Stock Fans, Mark October 29 on Your Calendar - Oct 26th, 2026 11:22 am
ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data - Oct 26th, 2026 9:58 am
Nasdaq-Listed Solana Company Gains Strategic Enterprise Status in Hong Kong - Oct 26th, 2026 7:23 am
Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer - Oct 25th, 2026 9:30 am
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer - Oct 25th, 2026 9:30 am
Can Roche Holding (SWX:ROP) Still Be Cheap After Fresh Trial Wins? - Oct 24th, 2026 10:14 am
AI Bubble Fears Trigger a Surprising Shift to Swiss Stocks - Oct 24th, 2026 3:36 am
Swiss stocks outperform Europe as investors retreat from AI trade - Bloomberg - Oct 24th, 2026 2:37 am
Stocktwits Biotech Dealmaker: Gilead And Roche Double Down On Early-Stage Assets Over Full Buyouts This Week - Oct 23rd, 2026 6:01 pm
Moderna’s Cancer-Vaccine Leak Spurs Panic Selling. Wall Street Wanted a Cure. - Oct 23rd, 2026 2:10 pm
Ionis partner Roche announces new Phase 3 data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN) - Oct 23rd, 2026 11:37 am
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN) - Oct 23rd, 2026 11:30 am
Genentech Presents Interim Phase III Data Showing Sefaxersen Significantly Reduced Proteinuria in People With IgA Nephropathy (IgAN) - Oct 23rd, 2026 11:30 am
U.S. Treasury Wants to Rein In Deals for Chinese Biotech and AI - Oct 23rd, 2026 10:52 am
Clinical Laboratory Molecular Diagnostics for Infectious Diseases Market, 2025-2029: Forecast by Application, Place, and Country | Multiplex and Rapid Testing Unlock Growth - Oct 23rd, 2026 8:07 am
NGS Kits Market Forecasts Growth from $6.84 Billion (2025) to $19.36 Billion by 2036, Profiling Illumina, Thermo Fisher Scientific, Roche, Oxford Nanopore & 11 Other Key Players - Oct 23rd, 2026 8:05 am
Zymeworks stock surges on $813M Roche licensing deal - Oct 23rd, 2026 7:25 am
Deutsche Bank upgrades Roche on bullish physician feedback for cancer drug - Oct 23rd, 2026 5:20 am